KR970005301A

KR970005301A - Blood pressure inhibitors with superoxide dismutase action

Info

Publication number: KR970005301A
Application number: KR1019950022923A
Authority: KR
Inventors: 아키히코 키무라; 아쭈시 타카다; 나오토 이시카와
Original assignee: 아키히코 키무라; 카부시키가이샤 토오요오학코오
Priority date: 1995-07-28
Filing date: 1995-07-28
Publication date: 1997-02-19

Abstract

안전하고 또 우수한 SOD작용을 보유하며, 또한 비타민C의 열화를 방지할 수 있는 발효조성물과, 비타민C또는 이것에 다시 녹차추출엑기스 혹은 그 증발잔여분을 배합한 혈압억제제를 제공한다.It provides a fermentation composition that has a safe and excellent SOD action and also prevents the deterioration of vitamin C, and a blood pressure suppressant comprising vitamin C or green tea extract extract or its evaporation residue.

본 발명의 혈압억제제는, 쌀겨류, 대두류, 탄소원 및 물을 포함하는 배양기에 발효시킨 콩의 균 혹은 마른풀의 균을 접종하고 통기교반하므로써 배양시키고, 여과해서 제조한 발효액 또는 그 발효액의 증발잔여분에 비타민C, 그리고 또 필요에 따라서 녹차추출엑기스(혹은 그 증발잔여분)을 함유시켜서 구성한다. 비타민C는 그 고형분환산으로 또, 녹차추출엑기스는 그 증발잔여분환산으로, 상기한 발효액의 증발잔여분 100중량부에 대하여, 각각 1∼30중량부 및 1∼50중량부가 배합되고, 또, 이 녹차추출엑기스는 에탄올 및/또는 물에서 추출된 수용성의 것을 사용할 수가 있다.Blood pressure inhibitor of the present invention is inoculated by inoculating the bacteria or fermentation of soybeans or dried grass fermented in the incubator containing rice bran, soybeans, carbon source and water, and aerated and filtered by fermentation broth or evaporation of the fermentation broth It is composed of vitamin C and the green tea extract extract (or the evaporation residue) as needed. Vitamin C in terms of its solid content and green tea extract extract in terms of its evaporation residue fraction, 1-30 parts by weight and 1-50 parts by weight, respectively, are blended with respect to 100 parts by weight of the evaporation residue of the fermentation broth. The extraction extract can be water soluble extracted from ethanol and / or water.

Description

Blood pressure inhibitors with superoxide dismutase action

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims

Cultured by inoculating with aeration and inoculation with soybean or fermented soybeans fermented in a liquid incubator containing rice bran, soybeans, carbon source and water and adjusted to pH 7.5 to 10 with alkaline agents. And a vitamin C in the fermentation broth prepared by filtration or the evaporation residue of the fermentation broth.

A fermentation broth prepared by inoculating, inoculated with the bacteria of soybeans or dry grass fermented in a liquid incubator containing rice bran, soybeans, a carbon source and water, and adjusting the pH to 5 to 10 with an alkaline agent, followed by incubation with aeration and filtering. A blood pressure suppressing agent, characterized in that the evaporation residue of the fermentation broth contains vitamin C and green tea extraction extract or the evaporation residue of the green tea extraction extract.

The blood pressure inhibitor according to claim 1, wherein the vitamin C is blended in an amount of 1 to 30 parts by weight based on 100 parts by weight of the evaporation residue of the fermentation broth in terms of its solid content.

The blood pressure inhibitor according to claim 2, wherein the vitamin C is blended in an amount of 1 to 30 parts by weight based on 100 parts by weight of the evaporation residue of the fermentation broth in terms of solid content.

3. The blood pressure inhibitor according to claim 2, wherein the green tea extract extract contains 1 to 50 parts by weight based on 100 parts by weight of the evaporation residue in the fermentation broth in terms of the evaporation residue fraction.

6. The blood pressure inhibitor according to any one of claims 2 and 5, wherein the green tea extract extract is water-soluble extracted from at least one of ethanol and water.

※ Note: The disclosure is based on the initial application.